Penn Spinout Verismo Therapeutics Receives FDA Clearance of Investigational New Drug Application for SynKIR-110™, a KIR-CAR T Cell Immunotherapy Candidate
Verismo plans to begin enrolling patients in the first quarter of 2023 at the initial clinical site, the Hospital of the University of Pennsylvania.
Penn Ranks Number 15 on Report of Top 100 Worldwide Universities Granted U.S. Utility Patents in 2021
The National Academy of Inventors & the Intellectual Property Owners Association ranked Penn in the Top 100 Worldwide Universities Granted U.S. Utility Patents in 2021.
The Weissman Lab is working towards developing vaccines that not only target multiple COVID variants, but also multiple types of coronaviruses.
On September 19, the PCI Fellows got together for their first in-person meeting since the cohort began in April.
PCI Fellows get exposure to a wide range of emerging technologies and commercialization opportunities in the life sciences, physical sciences, nanotechnology, and beyond.
Fiscal year 2022 saw the Co-Investment Program help launch and fund 2 new companies ViTToria Biotherapeutics and Dispatch Bio, as well as participate in follow-on rounds for Linnaeus Therapeutics, Car
For the 5th year, PCI partnered with the Penn Wharton Austin Alumni group to host a startup pitch session in conjunction with SXSW Interactive.
The 6th annual Celebration of Innovation returned in a hybrid format for 2021 with both attendees and award recipients participating in person and virtually.
From May 6 - 12, PCI participated in the 12th annual Philly Tech Week, a conference hosted by Technical.ly Philly, to showcase some of the city's best technology and innovation.
Penn spinout Capstan Therapeutics unites decades of combined experience in groundbreaking CAR therapies with the latest advances in mRNA delivery technology to find new cures for cancer and other dise